Dr Reddys Laboratories annual free cash flow
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Dr Reddys Laboratories Free Cash Flow (FCF) History (RDY)
Dr Reddys Laboratories reported ₹18.92B in free cash flow for fiscal 2025, a decrease of 34.81% from the previous fiscal year, with a free cash flow margin of 5.81%.
View full Dr Reddys Laboratories company overviewDr Reddys Laboratories free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-03-31 | ₹18.92B | −₹10.11B | −34.81% | +5.81% |
| 2024 | 2024-03-31 | ₹29.03B | −₹18.52B | −38.95% | +10.40% |
| 2023 | 2023-03-31 | ₹47.55B | ₹34.10B | +253.60% | +19.34% |
| 2022 | 2022-03-31 | ₹13.45B | −₹12.51B | −48.20% | +6.27% |
| 2021 | 2021-03-31 | ₹25.96B | ₹967.0M | +3.87% | +13.68% |
| 2020 | 2020-03-31 | ₹25.00B | ₹3.25B | +14.92% | +14.32% |
| 2019 | 2019-03-31 | ₹21.75B | ₹13.01B | +148.90% | +14.14% |
| 2018 | 2018-03-31 | ₹8.74B | −₹497.0M | −5.38% | +6.15% |
| 2017 | 2017-03-31 | ₹9.23B | −₹20.00B | −68.41% | +6.56% |
| 2016 | 2016-03-31 | ₹29.23B | — | — | +18.89% |
Dr Reddys Laboratories quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Dr Reddys Laboratories free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from ₹25.00B to ₹18.92B, a compound annual decline of 5.41%.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Dr Reddys Laboratories filings at SEC.gov ↗